Side-by-side comparison of AI visibility scores, market position, and capabilities
San Jose enterprise networking and security (NASDAQ: CSCO) at ~$57B annual revenue; $28B Splunk acquisition completed March 2024 integrating SIEM/SOAR with Cisco Security Cloud competing with Palo Alto Networks for enterprise cybersecurity.
Cisco Systems Inc. is a San Jose, California-based global technology conglomerate — publicly traded on NASDAQ (NASDAQ: CSCO) as a Dow Jones Industrial Average and S&P 500 component — generating approximately $57 billion in annual revenue and employing 86,000+ employees across 150+ countries, operating as the world's leading enterprise networking equipment manufacturer and an expanding cybersecurity and observability platform following the $28 billion acquisition of Splunk (completed March 2024, Cisco's largest-ever acquisition). Cisco's product portfolio spans networking (Catalyst switches, ASR routers, Meraki cloud-managed networking), security (Duo MFA, Cisco Firepower, Umbrella DNS security, SecureX XDR), collaboration (Webex conferencing, Webex Calling), data center (Nexus switches, UCS servers, HyperFlex HCI), and observability (Splunk SIEM/SOAR, AppDynamics APM, ThousandEyes network intelligence). CEO Chuck Robbins has led the company since 2015. Founded 1984 by Stanford computer scientists Leonard Bosack and Sandy Lerner.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.